Publications by authors named "Andreas Hilgeroth"

Claim this Profile
N
Novel Pyrrolopyrimidines as Inhibitors of CLK4 and HER2: Targeting Promising Anticancer Pathways.
Jonathan Gries, Frank Totzke, Andreas Hilgeroth

Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Novel Diaza Cage Compounds as MRP Modulators in Cancer Cells.
Henry Döring, David Kreutzer, Jannis von Veh, Christoph A Ritter, Andreas Hilgeroth

Anticancer Agents Med Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Antibacterial Evaluation of Novel Small-Molecule Antibacterials of a Reduced Acridine Structure in Strains Including MRSA.
Peter Werner, David Kreutzer, Nikoletta Szemeredi, Gabriella Spengler, Andreas Hilgeroth

Med Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Novel Benzo-annelated 1,4-dihydropyridines as MDR Modulators in Cancer Cells.
Peter Werner, Nikolétta Szemerédi, Gabriella Spengler, Andreas Hilgeroth

Anticancer Agents Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Evaluation of Novel Substituted N-Aryl 1,4-Dihydropyridines as Antituberculostatic Agents.
Lisa Seitz, Norbert Reiling, Christopher Vorreiter, Wolfgang Sippl, Sonja Kessler, Andreas Hilgeroth

Med Chem· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Effective Fluorinated Benzothiophene-Indole Hybrid Antibacterials against and MRSA Strains.
Marius Seethaler, Tobias Hertlein, Elisa Hopke, Paul Köhling, Knut Ohlsen, Andreas Hilgeroth

Pharmaceuticals (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel effective small-molecule inhibitors of protein kinases related to tau pathology in Alzheimer's disease.
Ansgar Opitz, Lisa-Marie Seitz, Vladimir Krystof, Fady Baselious, Max Holzer, Andreas Hilgeroth

Future Med Chem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. 2021, , 18.
Henry Döring, David Kreutzer, Christoph Ritter, Andreas Hilgeroth

Molecules· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDR Inhibitors for Anticancer Therapy.
Peter Werner, Andreas Hilgeroth

Anticancer Agents Med Chem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel class of small-molecule antibacterial agents against .
David Kreutzer, Robin Gehrmann, Annámaria Kincses, Nikoletta Szemerédi, Gabriella Spengler, Andreas Hilgeroth

Future Med Chem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Small-Molecule Hybrid-Antibacterial Agents against and MRSA Strains.
Robin Gehrmann, Tobias Hertlein, Elisa Hopke, Knut Ohlsen, Michael Lalk, Andreas Hilgeroth

Molecules· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Symmetrical Cage Compounds as Inhibitors of the Symmetrical MRP4-Efflux Pump for Anticancer Therapy.
David Kreutzer, Henry Döring, Peter Werner, Christoph A Ritter, Andreas Hilgeroth

Int J Mol Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy.
Henry Döring, David Kreutzer, Christoph Ritter, Andreas Hilgeroth

Molecules· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel effective antibacterial small-molecules against and strains.
Kaveh Yasrebi, Nico Schade, Emmanuel Tola Adeniyi, Björn Wecklein, Alba Ymeraj, Andreas Hilgeroth

Future Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Nonsymmetrical 1,4-Dihydropyridines as Inhibitors of Nonsymmetrical MRP-Efflux Pumps for Anticancer Therapy.
David Kreutzer, Christoph A Ritter, Andreas Hilgeroth

Pharmaceuticals (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibacterial Evaluation of Novel Substituted Cycloheptaindoles in Staphylococcus and Enterococcus Strains.
Andreas Hilgeroth, Kaveh Yasrebi, Sibel Suzen, Tobias Hertlein, Knut Ohlsen

Med Chem· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Small-molecule Antibacterials against Gram-positive Pathogens of and Species.
Marius Seethaler, Tobias Hertlein, Björn Wecklein, Alba Ymeraj, Knut Ohlsen, Andreas Hilgeroth

Antibiotics (Basel)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dually Acting Nonclassical 1,4-Dihydropyridines Promote the Anti-Tuberculosis (Tb) Activities of Clofazimine.
Fabian Lentz, Norbert Reiling, Gabriella Spengler, Annamária Kincses, Andrea Csonka, Andreas Hilgeroth

Molecules· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antistaphylococcal evaluation of indole-naphthalene hybrid analogs.
Kerolos Ashraf, Kaveh Yasrebi, Emmanuel Tola Adeniyi, Tobias Hertlein, Knut Ohlsen, Andreas Hilgeroth

Drug Des Devel Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance.
Tim Fischer, Abdulkarim Najjar, Frank Totzke, Christoph Schächtele, Wolfgang Sippl, Andreas Hilgeroth

J Enzyme Inhib Med Chem· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay.
Max Holzer, Nico Schade, Ansgar Opitz, Isabel Hilbrich, Jens Stieler, Andreas Hilgeroth

Molecules· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Enhancers of Isoniazid Toxicity in .
Fabian Lentz, Norbert Reiling, Ana Martins, Joseph Molnár, Andreas Hilgeroth

Molecules· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R.
Cornelius Hempel, Frank Totzke, Christoph Schächtele, Abdulkarim Najjar, Wolfgang Sippl, Andreas Hilgeroth

J Enzyme Inhib Med Chem· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Effective Small-Molecule Antibacterials against Enterococcus Strains.
Kerolos Ashraf, Kaveh Yasrebi, Tobias Hertlein, Knut Ohlsen, Michael Lalk, Andreas Hilgeroth

Molecules· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel substituted benzo-anellated 4-benzylamino pyrrolopyrimidines as dual EGFR and VEGFR2 inhibitors.
Tim Fischer, Thomas Krüger, Abdulkarim Najjar, Frank Totzke, Christoph Schächtele, Andreas Hilgeroth

Bioorg Med Chem Lett· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis